1.
Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.
Yoshida Noriko, Hisatomi Toshio, Ikeda Yasuhiro, Kohno Ri-ichiro, Murakami Yusuke, Imaki Hiroyuki et al.
Graefes Arch Clin Exp OphthalmolOct 201111 citationsCase Series
Intravitreal bevacizumab for neovascular glaucoma reduced inflammation, edema, and vascular congestion, plus caused endothelial cell degeneration in trabeculectomy specimens, suggesting its beneficial biological effects.